invasive cancer not presenting until 20 to 30 years of age. 10 , 11 Genetic screening should be performed for all patients presenting with MTC because surgery for early-stage disease is curative. 8 , 13 – 16 Before surgery, patients must undergo
Search Results
Stephanie A. Terezakis and Nancy Y. Lee
Samuel W. Beenken and Marshall M. Urist
. Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in 86 patients . Derm Surg 1997 ; 23 : 929 – 933 . 19 Boyer JD Zitelli JA Brodland DG D'Angelo G . Local control of primary Merkel cell carcinoma: review of 45
Nicholas Zdenkowski, Phyllis Butow, Andrew Spillane, Charles Douglas, Kylie Snook, Mark Jones, Christopher Oldmeadow, Sheryl Fewster, Corinna Beckmore, Frances M. Boyle, and for the Australia and New Zealand Breast Cancer Trials Group
downstaging the axilla 11 , 12 ; better oncologic clearance, allowing for consideration of immediate breast reconstruction in women still requiring mastectomy; improved prognostication based on response 13 ; time to plan surgery 14 ; and participation in a
Leila Family, Yanli Li, Lie Hong Chen, John H. Page, Zandra K. Klippel, and Chun Chao
or more of these pathogenic states may also increase risk of FN during chemotherapy. Specifically, we hypothesize that surgery, radiation therapy (RT), use of corticosteroids and antibiotics, and certain dermatologic/mucosal conditions might increase
Kelsey C. Stoltzfus, Biyi Shen, Leila Tchelebi, Daniel M. Trifiletti, Niraj J. Gusani, Vonn Walter, Ming Wang, and Nicholas G. Zaorsky
recommendations in the guidelines for other cancers, including breast and uterine, which are primarily treated with surgery. 4 Furthermore, previous studies analyzing facility volume are heterogeneous, with differing patient populations, outcome measures, and
Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop
during 2000–2008. The OCR does not capture stage of disease for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases. Reports were not available for patients with surgery in 2005; therefore, the study cohort
Shiva Kumar R. Mukkamalla, Hussain M. Naseri, Byung M. Kim, Steven C. Katz, and Vincent A. Armenio
), moderately differentiated (grade II), poorly differentiated (grade III), undifferentiated/anaplastic (grade IV), or unknown. Based on surgery and radiation information in the SEER database, we redefined treatment types into unknown, no treatment, surgery only
Stanley J. Miller, Murad Alam, James Andersen, Daniel Berg, Christopher K. Bichakjian, Glen Bowen, Richard T. Cheney, L. Frank Glass, Roy C. Grekin, Anne Kessinger, Nancy Y. Lee, Nanette Liegeois, Daniel D. Lydiatt, Jeff Michalski, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Thomas Olencki, Clifford S. Perlis, E. William Rosenberg, Ashok R. Shaha, Marshall M. Urist, Linda C. Wang, and John A. Zic
carcinomas that develop in the high-risk mask area of the face are more likely to recur and metastasize than those that develop on the trunk and extremities. Adapted with permission from Swanson NA. Mohs surgery: technique, indications, applications, and
Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston
borderline ovarian tumors (BOTs) and low-grade epithelial ovarian carcinomas (LG-EOCs) Assess the role of surgery, chemotherapy and fertility/hormonal preservation in the management of BOTs and LG-EOCs The International Federation of Gynecology and
Siddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, Kristin Mara, Kritika Prasai, Mohamed Hamdy Mady, Mohamed Hassan, Rory L. Smoot, Sean P. Cleary, Mark J. Truty, Lewis R. Roberts, and Amit Mahipal
gallbladder. Patient-related factors, such as age and functional status, are not included in the staging system. These factors and other laboratory parameters may be helpful in the prognostication of patients with GBC who are not candidates for surgery. 7 , 8
